

Ritsa Pharma Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 10.00 Cr
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.52 Cr
- Revenue Growth %
- Profit Growth -93.29%
- Ebitda -76.54%
- Net Worth -4182.62%
- Total Assets 18.82%
About Ritsa Pharma
Ritsa Pharma Private Limited (RPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 21 October 2020 (Four years and seven months 0 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company currently has active open charges totaling ₹4.52 Cr.
Ganji Kumar, Narendra Vutla, Venkateswara Yarlagadda, and Three other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290TG2020PTC145093
- Company No.
145093
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ritsa Pharma?
Board Members (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ganji Kumar ![]() | Director | 21-Oct-2020 | Current |
Narendra Vutla ![]() | Director | 07-Jul-2023 | Current |
Venkateswara Yarlagadda ![]() | Director | 21-Oct-2021 | Current |
Srilalitha Bhattaram ![]() | Director | 24-Feb-2021 | Current |
Manaswini Vemulapalli ![]() | Nominee Director | 09-Aug-2021 | Current |
Chandrasekhar Penugonda ![]() | Additional Director | 11-Jun-2024 | Current |
Financial Performance of Ritsa Pharma.
Ritsa Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 93.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 4182.62%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ritsa Pharma?
In 2023, Ritsa Pharma had a public holding of 50.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Vibrant Infrastructure Private Limited
Ganji Kumar is a mutual person
- Smart Agro Food Park Private Limited
Ganji Kumar is a mutual person
- Rev Snacks Private Limited
Ganji Kumar is a mutual person
- Hyderabad Angels Forum For Entrepreneurship Development
Ganji Kumar is a mutual person
- Airis Pharma Private Limited
Ganji Kumar and Srilalitha Bhattaram are mutual person
- Astir It Solutions Private Limited
Ganji Kumar is a mutual person
Charges (Loans)
₹4.52 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 4.52 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
21 Nov 2023 | State Bank Of India | ₹4.52 Cr | Open |
How Many Employees Work at Ritsa Pharma?
Unlock and access historical data on people associated with Ritsa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ritsa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ritsa Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Ritsa Pharma
Recent activity within the organization
- Director Appointment
Chandrasekhar Penugonda was appointed as a Additional Director was appointed as a Additional Director on 11 Jun 2024 & has been associated with this company since 11 months 10 days .
- Charges
A charge with State Bank Of India amounted to Rs. 4.52 Cr with Charge ID 100827380 was registered on 21 Nov 2023.
- Annual General Meeting
Ritsa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Director Appointment
Narendra Babu Vutla was appointed as a Director was appointed as a Director on 07 Jul 2023 & has been associated with this company since 1 year 10 months .
- Balance Sheet
Ritsa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Venkateswara Rao Yarlagadda was appointed as a Director was appointed as a Director on 21 Oct 2021 & has been associated with this company since 3 years 7 months .
Frequently asked questions
What is the Incorporation or founding date of Ritsa Pharma Private Limited?
Ritsa Pharma Private Limited was incorporated on 21 Oct 2020.
What is authorized share capital and paid-up capital of Ritsa Pharma Private Limited?
The authorized share capital of Ritsa Pharma Private Limited is ₹ 30.00 Cr and paid-up capital is ₹ 10.00 Cr.
Who are the current board members & directors of Ritsa Pharma Private Limited?
Currently 6 directors are associated with Ritsa Pharma Private Limited.
- Ganji Kishore Kumar
- Narendra Babu Vutla
- Venkateswara Rao Yarlagadda
- Srilalitha Bhattaram
- Manaswini Vemulapalli
- Chandrasekhar Penugonda
What is the registered address of Ritsa Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Ritsa Pharma Private Limited is 3600 Plot No. 4 Survey Nos. 101 101/2 340 Lalgadi Malakpet (Village), Genome Valley India, Tirumalagiri, Telangana, 500101.
What is the corporate identification number (CIN) and company number of Ritsa Pharma Private Limited?
The corporate identification number (CIN) of Ritsa Pharma Private Limited is U24290TG2020PTC145093 and the company number is 145093 as per Ministry of Corporate Affairs (MCA).
What is the official website of Ritsa Pharma Private Limited?
The Official website of Ritsa Pharma Private Limited is https://www.ritsapharma.com
What change has been observed in the net worth of Ritsa Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Ritsa Pharma Private Limited has experienced an downturn of -4182.62%.
What are the total open charges for Ritsa Pharma Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Ritsa Pharma Private Limited amount to ₹ 4.52 Cr.
When was the last Balance Sheet of Ritsa Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Ritsa Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
NB
Nirmala BhattaramDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India